理邦仪器股价微跌0.38% 上半年净利润同比增长23.47%

Company Overview - The stock price of Ribang Instrument is 13.13 yuan, down 0.05 yuan or 0.38% from the previous trading day. The intraday high was 13.29 yuan and the low was 13.05 yuan, with a trading volume of 84,167 hands and a transaction amount of 1.11 billion yuan [1]. Business Performance - Ribang Instrument operates in the medical device sector, focusing on the research, production, and sales of medical electronic equipment and in vitro diagnostic products. The product range includes patient monitoring, electrocardiogram diagnostics, maternal and child health, ultrasound imaging, in vitro diagnostics, and smart health [1]. - The company reported its 2025 semi-annual results, showing a revenue of 914 million yuan for the first half of the year, a decrease of 0.91% year-on-year. The net profit attributable to the parent company was 154 million yuan, an increase of 23.47% year-on-year, while the net profit excluding non-recurring items was 145 million yuan, up 26.78% year-on-year [1]. - In the second quarter, the revenue was 493 million yuan, reflecting a year-on-year growth of 3.1%, and the net profit attributable to the parent company was 89.36 million yuan, an increase of 3.2% year-on-year [1]. - International business revenue reached 557 million yuan, growing by 8.33% year-on-year, while domestic market revenue was 356 million yuan, down 12.56% year-on-year [1]. Market Activity - On August 25, the net outflow of main funds was 6.67 million yuan, with a cumulative net outflow of 46.30 million yuan over the past five days [2].